Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 2/2004

Content (10 Articles)

Original Paper

Induction of differentiation and peroxisome proliferator-activated receptor γ expression in colon cancer cell lines by troglitazone

Masashi Kato, Tomomi Kusumi, Shigeki Tsuchida, Masanori Tanaka, Mutsuo Sasaki, Hajime Kudo

Original Paper

Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma

Anil Potti, Nauman Moazzam, Eric Langness, Kaley Sholes, Ketki Tendulkar, Michael Koch, Steve Kargas

Original Paper

Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma

Vajarabhongsa Bhudhisawasdi, Kanha Muisuk, Premjai Areejitranusorn, Churairat Kularbkaew, Tueanjit Khampitak, O-Tur Saeseow, Sopit Wongkham

Original Paper

Report of a user-satisfaction analysis of a service provider for an oncology clinic

Michael Hartmann, Holger Knoth, Daniel Kühne

Original Paper

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer

Hiromasa Tsukino, Yoshiki Kuroda, Hiroyuki Nakao, Hirohisa Imai, Hisato Inatomi, Yukio Osada, Takahiko Katoh

Original Paper

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphoma

Hisashi Tsurumi, Toshiki Yamada, Michio Sawada, Senji Kasahara, Nobuhiro Kanemura, Yasushi Kojima, Kenji Fukuno, Takeshi Hara, Masanao Saio, Takeshi Takahashi, Masami Oyama, Keiya Ozawa, Tsuyoshi Takami, Hisataka Moriwaki

Original Paper

The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma

Bożena Konopka, Aneta Janiec-Jankowska, Zygmunt Paszko, Marian Goluda

Rapid Communication

Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder

M. Birlik, S. Akar, E. Tuzel, F. Onen, E. Ozer, M. Manisali, Z. Kirkali, N. Akkoc

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine